CNBC's Bertha Coombs reports the latest on how Cigna is suing Anthem and expanding its buyback program to a total of $3.7 billion.
CNBC's Bertha Coombs reports the latest on Anthem responding by saying Cigna does not have the right to terminate the deal.
Anthem will appeal a federal court ruling rejecting its $54 billion merger with Cigna and asked for an expedited hearing to make its case.
Is the end near for the Anthem-Cigna deal? CNBC's Bertha Coombs reports on where the deal currently stands.
Coca-Cola, Twitter, Anthem, and Cigna stocks are making headlines on Walll Street.
A federal judge ruled against U.S. health insurer Anthem's proposed $54 billion merger with smaller rival Cigna.
The ruling marks another victory for anti-trust officials, who sued the companies in July last year to stop the deal.
President Donald Trump has said he wants to repeal and replace the Affordable Care Act soon.
U.S. equities closed mostly higher on Wednesday after the Federal Reserve kept interest rates unchanged, as was widely expected.
U.S. stock index futures pointed to a higher open on Wednesday as traders eyed the latest announcement from the Federal Reserve.
U.S. equities traded mixed as investors continued to evaluate the latest policies from the White House.
The No. 3 U.S. health insurer's total revenue rose about 5 percent to $15.73 billion but was below expectations.
Stocks notched their worst day of 2017, as a new measure taken by the Trump administration on immigration sent jitters through the market.
Some of the names on the move ahead of the open.
With hopes for megamergers dashed and Obamacare-fueled growth in question, investors need answers from health insurers.
Markets will be busy with economic reports and earnings, but Washington could continue to dominate.
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry."
Short-seller Andrew Left, Citron Research, explains why Express Scripts is the "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct with Valeant Pharmaceuticals.
If Aetna and Humana merge, will the 17 million seniors in the Medicare Advantage market be left with too little choice for health insurance?
CNBC looked at a list of S&P 500 names with tax rates between 10 and 45 percent in fiscal 2015.